Health funding is increasingly based on the results of economic evaluation. But current
methods fail to consider all society's health objectives and are too complex for policy makers …

… Joanna Coast, professor of health economics2 … Richard Smith and Joanna Coast
argue that current estimates of the cost of antibiotic resistance are misleading and may …

This paper explores the spread of ideas within health economics, in relation to the impact of
the capability approach to date and the extent to which it might impact in the future. The …

This editorial questions the implications of the capability approach for health economics. Two
specific issues are considered: the evaluative space of capablities (as opposed to health or …

Objectives. Cost-utility analysis in which health benefits are quantified in terms of quality-adjusted
life-years (QALYs) has now become the standard type of cost-effectiveness analysis. …

This paper argues that increasing resistance to antimicrobials is an important social
externality that has not been captured at the level of economic appraisal. The paper explicitly …

Statements like “quality of care is more highly valued than waiting time” can neither be
supported nor refuted by comparisons of utility parameters from a traditional discrete choice …

Importance Patient-reported outcome (PRO) data from clinical trials can provide valuable
evidence to inform shared decision making, labeling claims, clinical guidelines, and health …

Purpose The benefits of health and social care are not confined to patient health alone and
therefore broader measures of wellbeing may be useful for economic evaluation. This paper …

This paper reports the first application of the capabilities approach to the development and
valuation of an instrument for use in the economic evaluation of health and social care …